TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes in scaled scores of the Pediatric Evaluation of Disability Inventory - Computerized Adapted Test (PEDI-CAT)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in walking distance on the 6-Minute Walk Test (6WMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in values of Respiratory Sinus Arrhythmia (RSA) derived from Heart Rate Variability as captured by ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of mean fundamental frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of jitter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of voice strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically excellent-Success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intraoperative peak inspiratory pressure (PIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severe postoperative complications (Clavien-Dindo IIIb or higher)
Endpoint domain: Adverse events/effects
Primary endpoint: Readmission (at least one night in hospital)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Post-Traumatic Stress Disorder Checklist Scale for DSM-5
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-Traumatic Growth Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ways of Coping Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of mild stable DCM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rate (ORR) by RECIST v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accurate rate for language related cortex localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment success at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fidelity of VRP use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the app intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability and interaction with the app
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Accessibility of the app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occlusal contacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrical Synchronization Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Measurement of occlusal prematurity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of recovery score (QoR-15)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Development of de novo donor-specific antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Biopsy-proven acute rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of significant (2+) interstitial fibrosis/tubular atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: White Spot Lesion severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for tubing placement direction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lymphedema change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Physical Function associated with osteoarthritis
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Exercise sessions attendance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Recruitment, refusal, and retention rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 1-year rate of Net Adverse Clinical Events (NACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Experienced an Adverse Event (AE) During Blinded Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Discontinued From Blinded Study Treatment Due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of acne-related pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in the upper limb' joints range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant changes from Baseline vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VSCs levels (hydrogen sulfide, methyl-mercaptan, dimethyl sulfide)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAP integral
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of central venous catheter colonization
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Greater Than or Equal to (≥) 5% Body Weight Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: splenic embolisation (SE) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DMN-Insula fMRI brain connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: insular glutamate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: proportion of participants with KS with remission and recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Evidence of Luteal Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of urinary incontinence at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of urinary incontinence at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Drug survival rate
Endpoint domain: Mortality/survival
Primary endpoint: American College of Rheumatology pediatric (ACR Pedi) 30/50/70/90 achievement rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical remission/inactive disease rates by Wallace criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score in the Treatment Satisfaction Questionnaire for Erenumab (TSQM) overall satisfaction scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Behavior Rating Inventory of Executive Functions-2
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Adverse Childhood Experiences Scales (ACES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Test UP and GO performance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Four Square Step Test performance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in anxiety symptoms (RCADS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in anxiety symptoms (RCADS-P)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in anxiety symptoms (CGC-I)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity of anxiety symptoms (CGC-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mitochondrial function in skeletal and cardiac muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adherence to the Weekly COVID-19 Testing Schedule
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Edmonton Symptom Diagnostic Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EORTC QLQ-C 30 Quality of Life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Student Satisfaction and Self-Confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Aberrant behavior checklist
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Repetitive Behavior Scale - Revised
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Risk classification for OSA Syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of Accessing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reasons for staying in hospital
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Conduct Problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: employment attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: healthy financial attitudes
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: treatment-related adverse events (TRAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Achieving Responder Status Based on MFVDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: engraftment of genetically modified cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Suprascapular notch cross-sectional area measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Perception of Mouth Dryness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: severity of acute rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Walking Speed with no intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking Speed with intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Experiential Avoidance in Caregiving Questionnaire (EACQ) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Short Form Zarit Burden Interview (ZBI-SF) Score
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change in Positive Aspects of Caregiving (PAC) Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of days of substance use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of adverse events leading to permanent treatment discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Liking of each test food
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ranked preference of each test food
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in Best Corrected Visual Acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life-Assessment of Adult Growth Hormone in Adults
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: risk of protocol-defined safety events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of protective antibodies against suxamethonium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Possible Related Adverse Events Grade 3 or 4
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Number of Participants With Post-operative Infectious and Inflammatory Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of conversion to complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positivity of the procedure in Diagnosis and Subtyping of lymphoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Occurrence and numbers of DLT
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence and frequency of AE and SAE
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients alive at Day 30
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients with an overall response of treatment success at end of study treatment (EOST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Anxiety Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Comprehension of survivorship care recommendations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comprehension of prostate specific antigen surveillance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comprehension of treatment side effects and late effects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rates of intervention completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in completion of advance directives
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fibrinogen Contribution to Clot Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants reporting solicited administration site events within 7 days post-Dose 1
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting solicited systemic events within 7 days post-Dose 1
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting unsolicited adverse events (AEs) within 29 days post-Dose 1
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of doses not completed within three days of the expected date
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent change in liver fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: pathological complete remission (pCR)
Endpoint domain: Mortality/survival
Primary endpoint: invasive disease-free survival rate (iDFS)
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with self-reported and bioverified abstinence from smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in rhinoconjunctivitis quality of life questionnaire (RQLQ) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Patients With Treatment-related Adverse Events (AEs) as Measured by Vital Signs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With Treatment-related AEs as Measured by Physical Examinations
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With Treatment-related AEs as Measured by Clinical Laboratory Testing
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With Treatment-related AEs as Measured by Electrocardiogram
Endpoint domain: Adverse events/effects
Primary endpoint: Nasal blood flow change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak nasal inspiratory flow change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported DNDWD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in soft tissue healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mid crestal soft tissue thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mid-buccal soft tissue height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of urticaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Best-corrected visual acuity (BCVA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraventricular hemorrhage (IVH) Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Incidence of radiation induced dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: anatomical changes in the pelvic floor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in QoL reported by patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: changes in micturition and sexual function reported by patients
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Therapy-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage Change in Lumbar Spine Bone Mineral Density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: circumference of the edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: edema status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of IMAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in phosphorylated alpha-synuclein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with abnormal Vital signs: Blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with abnormal Vital signs: Pulse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with abnormal values in haematology: complete blood count (CBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants with abnormal values in haematology: white blood cell (WBC) count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: risk of device infection leading to surgical intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Physical features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self efficacy on basic breastfeeding knowledge and skills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Level of knowledge and skill in caring for newborn baby and breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in olfaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capable Feeding Skills at Discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 1L treatment outcomes with ECA 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1L treatment outcomes with ECA 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1L treatment outcomes with ECA 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1L treatment outcomes with ECA 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Selective Attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Forward Digit Span
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Backward Digit Span
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Digit Sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Inhibitory Control and Cognitive Flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Maximum Tolerated Dose (MTD) or recommend Phase II dose (RP2D)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Experiencing Any Treatment Emergent Adverse Events (TEAE) and Treatment Related Adverse Events (TRAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Unplanned removal of devices
Endpoint domain: Adverse events/effects
Primary endpoint: Positive & Negative Symptom Scale total (PANSSt)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: World Health Organization Disability Schedule (WHODAS 2.0)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: MATRICS Consensus Cognitive Battery Global Composite T-score (MCCB-C)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage change in muscle loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: compliance to illness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: catheter-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluate the baby's sucking while breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluate of Sore nipples
Endpoint domain: Adverse events/effects
Primary endpoint: Evaluate Nipple pain
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of secondary fractures
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity-True Positive Rate (TPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity-True Negative Rate (TNR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of hepatocytes transduced with AAV vector genome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nature of gut microbiota bacterial proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Nature of gut microbiota taxonomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Relative quantification of gut microbiota bacterial proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes